Clinical Trial Update: An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on the efficacy and safety evaluation of Serostim for maintaining treatment effects in HIV-associated adipose redistribution …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-associated Adipose Redistribution Syndrome

Drugs mentioned

• SEROSTIM (somatropin)

Snippet

Sponsor: EMD Serono | Conditions: Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS), Human Immunodeficiency Virus Infections | Phase 2, Phase 3 | Status: COMPLETED